Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Eclampsia | 10 | 2012 | 202 | 2.160 |
Why?
|
| Vitamin D | 7 | 2013 | 516 | 1.110 |
Why?
|
| Pregnancy Complications | 5 | 2013 | 286 | 0.800 |
Why?
|
| Labor, Induced | 3 | 2010 | 18 | 0.780 |
Why?
|
| Pregnancy Outcome | 4 | 2010 | 157 | 0.770 |
Why?
|
| Pregnancy | 16 | 2013 | 2331 | 0.670 |
Why?
|
| Pregnancy Proteins | 3 | 2012 | 15 | 0.590 |
Why?
|
| Vitamin D Deficiency | 5 | 2013 | 292 | 0.510 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2011 | 44 | 0.480 |
Why?
|
| Cesarean Section | 3 | 2010 | 101 | 0.430 |
Why?
|
| Fetal Development | 1 | 2011 | 70 | 0.380 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2009 | 27 | 0.340 |
Why?
|
| Obesity, Morbid | 1 | 2010 | 172 | 0.320 |
Why?
|
| Gestational Age | 6 | 2010 | 389 | 0.310 |
Why?
|
| Case-Control Studies | 5 | 2012 | 1548 | 0.300 |
Why?
|
| Body Mass Index | 1 | 2010 | 866 | 0.290 |
Why?
|
| Antigens, CD | 1 | 2007 | 230 | 0.290 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 248 | 0.280 |
Why?
|
| Research Design | 1 | 2009 | 729 | 0.260 |
Why?
|
| Logistic Models | 3 | 2012 | 1419 | 0.220 |
Why?
|
| Female | 17 | 2013 | 38015 | 0.200 |
Why?
|
| Confidence Intervals | 2 | 2012 | 242 | 0.200 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2000 | 79 | 0.190 |
Why?
|
| Cleft Palate | 1 | 2000 | 34 | 0.190 |
Why?
|
| Cleft Lip | 1 | 2000 | 33 | 0.180 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2008 | 58 | 0.180 |
Why?
|
| Adult | 9 | 2012 | 21375 | 0.170 |
Why?
|
| Elective Surgical Procedures | 2 | 2010 | 95 | 0.170 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 1046 | 0.160 |
Why?
|
| Placenta Growth Factor | 3 | 2012 | 12 | 0.150 |
Why?
|
| Humans | 17 | 2013 | 68525 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2007 | 24 | 0.150 |
Why?
|
| Infant, Newborn | 3 | 2013 | 2453 | 0.140 |
Why?
|
| ROC Curve | 3 | 2012 | 392 | 0.140 |
Why?
|
| Biomarkers | 3 | 2012 | 1593 | 0.140 |
Why?
|
| Young Adult | 3 | 2012 | 5708 | 0.140 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1851 | 0.130 |
Why?
|
| Ergocalciferols | 1 | 2013 | 40 | 0.110 |
Why?
|
| Cross-Sectional Studies | 2 | 2010 | 2264 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2012 | 122 | 0.110 |
Why?
|
| Area Under Curve | 1 | 2012 | 238 | 0.100 |
Why?
|
| Lactation | 1 | 2012 | 110 | 0.100 |
Why?
|
| Fetal Macrosomia | 1 | 2010 | 7 | 0.100 |
Why?
|
| Gravidity | 1 | 2010 | 11 | 0.100 |
Why?
|
| Apgar Score | 1 | 2010 | 22 | 0.100 |
Why?
|
| Radioimmunoassay | 1 | 2010 | 164 | 0.090 |
Why?
|
| Cesarean Section, Repeat | 1 | 2010 | 4 | 0.090 |
Why?
|
| Causality | 1 | 2010 | 81 | 0.090 |
Why?
|
| Intensive Care, Neonatal | 1 | 2010 | 38 | 0.090 |
Why?
|
| Risk Factors | 2 | 2010 | 5719 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2012 | 880 | 0.090 |
Why?
|
| Birth Weight | 1 | 2010 | 186 | 0.090 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2010 | 91 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2013 | 929 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2009 | 186 | 0.080 |
Why?
|
| Infant Mortality | 1 | 2008 | 59 | 0.080 |
Why?
|
| Uterine Prolapse | 1 | 2008 | 29 | 0.080 |
Why?
|
| Endoglin | 1 | 2007 | 3 | 0.080 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2007 | 15 | 0.080 |
Why?
|
| Incidence | 1 | 2010 | 1582 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 384 | 0.060 |
Why?
|
| South Carolina | 1 | 2010 | 2750 | 0.060 |
Why?
|
| Obesity | 1 | 2010 | 1074 | 0.050 |
Why?
|
| Infant | 1 | 2008 | 2891 | 0.050 |
Why?
|
| Vitamins | 2 | 2012 | 134 | 0.050 |
Why?
|
| United States | 2 | 2012 | 7335 | 0.050 |
Why?
|
| Dietary Supplements | 2 | 2013 | 331 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2010 | 7264 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2007 | 2688 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 689 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2000 | 3702 | 0.030 |
Why?
|
| Maternal Welfare | 1 | 2012 | 17 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2013 | 117 | 0.030 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2012 | 37 | 0.030 |
Why?
|
| Sunlight | 1 | 2012 | 59 | 0.030 |
Why?
|
| Immune System | 1 | 2012 | 63 | 0.030 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2012 | 58 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2012 | 117 | 0.030 |
Why?
|
| Milk, Human | 1 | 2012 | 147 | 0.020 |
Why?
|
| Models, Economic | 1 | 2010 | 69 | 0.020 |
Why?
|
| Florida | 1 | 2010 | 221 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2010 | 193 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2012 | 7028 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2013 | 1737 | 0.020 |
Why?
|
| Valsalva Maneuver | 1 | 2008 | 10 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 503 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 848 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 737 | 0.020 |
Why?
|
| Length of Stay | 1 | 2010 | 780 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 507 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 1753 | 0.010 |
Why?
|
| Algorithms | 1 | 2008 | 1194 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 4655 | 0.010 |
Why?
|
| Hypertension | 1 | 2007 | 1531 | 0.010 |
Why?
|
| Aged | 1 | 2008 | 14842 | 0.010 |
Why?
|
| Middle Aged | 1 | 2008 | 21119 | 0.010 |
Why?
|